<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Hum Mol Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Hum. Mol. Genet</journal-id>
<journal-id journal-id-type="publisher-id">hmg</journal-id>
<journal-title-group>
<journal-title>Human Molecular Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">0964-6906</issn>
<issn pub-type="epub">1460-2083</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31174205</article-id>
<article-id pub-id-type="pmc">6736288</article-id>
<article-id pub-id-type="doi">10.1093/hmg/ddz123</article-id>
<article-id pub-id-type="publisher-id">ddz123</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>General Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Chronic mTORC1 inhibition rescues behavioral and biochemical deficits resulting from neuronal <italic>Depdc5</italic> loss in mice</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Yuskaitis</surname>
<given-names>Christopher J</given-names>
</name>
<!--<email>Christopher.Yuskaitis@childrens.harvard.edu</email>-->
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rossitto</surname>
<given-names>Leigh-Ana</given-names>
</name>
<!--<email>Leigh-Ana.Rossitto@childrens.harvard.edu</email>-->
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gurnani</surname>
<given-names>Sarika</given-names>
</name>
<!--<email>Sarikag44@gmail.com</email>-->
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bainbridge</surname>
<given-names>Elizabeth</given-names>
</name>
<!--<email>Bainbridge.el@gmail.com</email>-->
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Poduri</surname>
<given-names>Annapurna</given-names>
</name>
<!--<email>Annapurna.Poduri@childrens.harvard.edu</email>-->
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0001-7044-2953</contrib-id>
<name>
<surname>Sahin</surname>
<given-names>Mustafa</given-names>
</name>
<!--<email>mustafa.sahin@childrens.harvard.edu</email>-->
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff3">3</xref>
<xref ref-type="corresp" rid="cor1"></xref>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label>Department of Neurology, F.M. Kirby Neurobiology Center, Boston Children’s Hospital, Boston, MA, USA</aff>
<aff id="aff2"><label>2</label>Division of Epilepsy and Clinical Neurophysiology and Epilepsy Genetics Program, Boston Children’s Hospital, Boston, MA, USA</aff>
<aff id="aff3"><label>3</label>Department of Neurology, Harvard Medical School, Boston, MA, USA</aff>
<author-notes>
<corresp id="cor1">To whom correspondence should be addressed at: Boston Children’s Hospital, 300 Longwood Ave, Boston, MA 02115, USA. Tel: 617-919-4518; Fax: 617-730-0340; Email: <email>Mustafa.Sahin@childrens.harvard.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>01</day>
<month>9</month>
<year>2019</year>
</pub-date>
<pub-date iso-8601-date="2019-05-17" pub-type="epub">
<day>17</day>
<month>5</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>9</month>
<year>2020</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>28</volume>
<issue>17</issue>
<fpage>2952</fpage>
<lpage>2964</lpage>
<history>
<date date-type="received">
<day>28</day>
<month>3</month>
<year>2019</year>
</date>
<date date-type="rev-recd">
<day>31</day>
<month>5</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>4</day>
<month>6</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="publisher-standard" xlink:href="https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model">
<license-p>This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (<ext-link ext-link-type="uri" xlink:href="https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model">https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model</ext-link>)</license-p>
</license>
</permissions>
<self-uri xlink:href="ddz123.pdf"></self-uri>
<abstract>
<title>Abstract</title>
<p>
<italic>DEPDC5</italic> is now recognized as one of the genes most often implicated in familial/inherited focal epilepsy and brain malformations. Individuals with pathogenic variants in <italic>DEPDC5</italic> are at risk for epilepsy, associated neuropsychiatric comorbidities and sudden unexplained death in epilepsy. <italic>Depdc5</italic><sup><italic>f</italic>lox/flox</sup>-<italic>Syn1</italic><sup>Cre</sup> (<italic>Depdc5</italic>cc+) neuronal-specific <italic>Depdc5</italic> knockout mice exhibit seizures and neuronal mTORC1 hyperactivation. It is not known if <italic>Depdc5</italic>cc+ mice have a hyperactivity/anxiety phenotype, die early from terminal seizures or whether mTOR inhibitors rescue <italic>DEPDC5</italic>-related seizures and associated comorbidities. Herein, we report that <italic>Depdc5</italic>cc+ mice were hyperactive in open-field testing but did not display anxiety-like behaviors on the elevated-plus maze. Unlike many other mTOR-related models, <italic>Depdc5</italic>cc+ mice had minimal epileptiform activity and rare seizures prior to seizure-induced death, as confirmed by video-EEG monitoring. Treatment with the mTORC1 inhibitor rapamycin starting after 3 weeks of age significantly prolonged the survival of <italic>Depdc5</italic>cc+ mice and partially rescued the behavioral hyperactivity. Rapamycin decreased the enlarged brain size of <italic>Depdc5</italic>cc+ mice with corresponding decrease in neuronal soma size. Loss of <italic>Depdc5</italic> led to a decrease in the other GATOR1 protein levels (NPRL2 and NPRL3). Rapamycin failed to rescue GATOR1 protein levels but rather rescued downstream mTORC1 hyperactivity as measured by phosphorylation of S6. Collectively, our data provide the first evidence of behavioral alterations in mice with <italic>Depdc5</italic> loss and support mTOR inhibition as a rational therapeutic strategy for <italic>DEPDC5-</italic>related epilepsy in humans.</p>
</abstract>
<funding-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institutes of Health</named-content>
<named-content content-type="funder-identifier">10.13039/100000002</named-content>
</funding-source>
<award-id>2R25NS070682-07</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institute of Neurological Disorders and Stroke</named-content>
<named-content content-type="funder-identifier">10.13039/100000065</named-content>
</funding-source>
<award-id>K12NS098482</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">Boston Children’s Hospital Basic/Translational Research Executive Committee Career Development Fellowship</named-content>
</funding-source>
<award-id>U54HD090255</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">Translational Research Program at Boston Children’s Hospital</named-content>
</funding-source>
</award-group>
</funding-group>
<counts>
<page-count count="13"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>